The effect of CXCL1 on human fetal oligodendrocyte progenitor cells

GLIA

Volumn 56, Issue 1, 2008, Pages 1-15

  Filipovic, Radmila ^a   Zecevic, Nada ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Astrocytes; Interleukin 6; Phospho ERK1 2; Slice cultures; Subventricular zone

Indexed keywords

CXCL1 CHEMOKINE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FETUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; OLIGODENDROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STEM CELL; SUBVENTRICULAR ZONE;

ANTIMETABOLITES; ASTROCYTES; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL COUNT; CELL PROLIFERATION; CHEMOKINE CXCL1; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-6; OLIGODENDROGLIA; ORGAN CULTURE TECHNIQUES; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 36448939029     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20582     Document Type: Article

References (72)

1. Althaus HH, Kloppner S, Schmidt-Schultz T, Schwartz P. 1992. Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain. Neurosci Lett 135:219-223.
2. Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq ME. 1992. Pre-oligodendrocytes from adult human CNS. J Neurosci 12:1538-1547.
3. Asensio VC, Campbell IL. 1999. Chemokines in the CNS: Plurifunctional mediators in diverse states. Trends Neurosci 22:504-512.
4. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. 2001. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21:1302-1312.
5. Baggiolini M, Dewald B, Moser B. 1997. Human chemokines: An update. Ann Rev Immunol 15:675-705.
6. Bhat S, Pfeiffer SE. 1986. Stimulation of oligodendrocytes by extracts from astrocyte-enriched cultures. J Neurosci Res 15:19-27.
7. Brown DR, Kretzschmar HA. 1998. The glio-toxic mechanism of α-amino adipic acid on cultured astrocytes. J Neurocytol 27:109-118.
8. Chang A, Tourtellote WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Eng J Med 346:165-173.
9. Diab A, Zhu J, Xiao BG, Mustafa M, Link H. 1997. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J Neuropathol Exp Neurol 56:641-650.
10. Di Marco R, Khademi M, Wallstrom E, Iacobaeus E, Salvaggioo A, Carcappa S, Papoian R., Nicoletti F, Olsson T. 2001. Curative effects of recombinant human Inteleukin-6 in DA rats with protracted relapsing remitting experimental allergic encephalomyelitis. J Neuroimmunol 116:168-177.
11. Dubois Dalcq M, Murray K. 2000. Why are growth factors important in oligodendrocyte physiology? Pathol Biol Paris 48:80-86.
12. Eyupoglu IY, Bechmann I, Nitsch R. 2003. Modification of microglia function protects from lesion-induced neuronal alteration and promotes sprouting in the hippocampus. FASEB J 17:1110-1111.
13. Filipovic R, Jakovcevski I, Zecevic N. 2003. GRO-α and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neurosci 25:279-290.
14. Filipovic R, Rakic S, Zecevic N. 2002. Expression of Golli proteins in adult human brain and multiple sclerosis lesions. J Neuroimmunol 127:1-12.
15. Filipovic R, Zecevic N. 2005. Lipopolysaccharide affects Golli expression and promotes proliferation of oligodendrocyte progenitors. Glia 49:457-466.
16. Flores AI, Mallon BS, Matsui T, Ogawa W, Rosenzweig A, Okamoto T, Macklin WB. 2000. Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci 20:7622-7630.
17. Franklin RJM. 2002. Why does remyelination fail in multiple sclerosis? Nature Rev 3:705-714.
18. + GalC-oligodendrocyte progenitors. Dev Biol 159:618-630.
19. Glabinski AR, O'Bryant S, Selmaj K, Ransohoff R. 2000. CXC chemokine receptors expression during relapsing experimental autoimmune encephalomyelitis. Ann NY Acad Sci 917:135-144.
20. Glabinski AR, Ransohoff RM. 1999. Chemokines and chemokine receptors in CNS pathology. J Neurovirol 5:3-12.
21. Grinspan J. 2002. Cells and signaling in oligodendrocyte development. J Neuropathol Exp Neurol 61:297-306.
22. Heinrich PC, Behrmann I, Muller-Newen G, Scarper F, Grave L. 1998. Interleukin-6-type cytokine signaling through gp130/JAK/STAT pathway. J Biochem 334:297-314.
23. Hessen M, Tanabe S, Berman MA, Yoshizawa I, Luo Y, Kim RJ, Post TW, Gerard C, Dorf ME. 1996. Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transciptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. J Neurosci Res 45:382-391.
24. Hitoshi S, Tropepe V, Ekker M, van der Kooy D. 2002. Neural stem cell lineages are regionally specified, but not committed, within distinct compartments of the developing brain. Development 129:233-244.
25. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC. 1997. Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158:2882-2890.
26. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD. 2006. Astrocytes promote myelination in response to electrical impulses. Neuron 49:823-832.
27. Jakovcevski I, Zecevic N. 2005. Sequence of oligodendrocyte development in the human fetal telencephalon. Glia 49:480-491.
28. Kadi L, Selvaraju R, de Lys P, Proudfoot AE, Wells TN, Boschert U. 2006. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol 174: 133-146.
29. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD. 2006. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 9:173-179.
30. Kumar S, Kahn MA, Dinh L, de Vellis J. 1998. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J Neurosci Res 54:754-765.
31. Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B, Baron-Van Evercooren A. 2002. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Moll Cell Neurosci 20:390-403.
32. Lee YB, Nagai A, Kim SU. 2002. Cytokines, chemokines and cytokine receptors in human microglia. J Neurosci Res 69:94-103.
33. Levine JM, Reynolds R, Fawcett JW. 2001 The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24:39-47.
34. Luskin MB. 1993. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 11:173-189.
35. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE. 2003. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23:7710-7718.
36. Mc Carthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
37. Mo Z, Moore A, Filipovic R, Ogawa Y, Kazuhiro I, Antic S, Zecevic N. 2007. Human cortical neurons originate from radial glia and neuron-restricted progenitors. J Neurosci 27:4132-4145.
38. Murphy PM. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593-633.
39. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. 2007. Activation of subventricular zone in multiple sclerosis: Evidence for early glial progenitors. Proc Natl Acad Ssi USA 104:4694-4699.
40. Ness JK, Mitchell NE, Wood TL. 2002. IGF-I and NT-3 signaling pathways in developing oligodendrocytes: Differential regulation and activation of receptors and downstream effector Akt. Dev Neurosci 24: 437-445.
41. Nguyen D, Stangel M. 2001. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Dev Brain Res 128: 77-81.
42. Noble M, Murray K. 1984. Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J 3:2243-2247.
43. Omari KM, John G, Lango R, Raine CS. 2006. Role of CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53:24-31.
44. Omari KM, John GR, Sealfon SC, Raine CS. 2005. CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain 128:1003-1015.
45. Padovani-Claudio DA, Liu L, Ransohoff RM, Miller RH. 2006. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia 54:471-483.
46. Pizzi M, Sarnico I, Baroni F, Banarese M, Dreano M, Garotta G, Valerio A, Spano P. 2005. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 recetror/IL-6 fusion protein in organotypic hippocampal slice. Mol Cell Neurosci 25:301-311.
47. Pringle NP, Mudhar HS, Collarini EJ, Richardson WD. 1992. PDGF receptor in the rat CNS: During late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glia cells of oligodendrocyte lineage. Development 115:535-551.
48. Raine CS, Scheinberg L, Waltz JM. 1981. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesions. Lab Invest 45:534-546.
49. Rakic S, Zecevic N. 2003. Early oligodendrocyte progenitor cells in the human fetal telencephalon. Glia 41:117-127.
50. Ransohoff RM, Howe CL, Rodriguez M. 2002. Growth factor treatment of demyelinating disease: At last, a leap into the light. Trends Neurosci 22:512-515.
51. Ray J, Gage FH. 2005. Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Mol Cell Neurosci 31:560-573.
52. Rezaie P, Trillo-Pazos G, Everall IP, Male DK. 2002. Expression of β-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: Potential role of chemokines in the developing CNS. Glia 37:64-75.
53. Richardson WD, Kessaris N, Pringle N. 2006. Oligodendrocyte wars. Nat Rev Neurosci 7:11-18.
54. Robinson S, Franic LA. 2001. Chemokine GRO1 and the spatial and temporal regulation of oligodendrocyte precursor proliferation. Dev Neurosci 23:338-345.
55. Robinson S, Tani M, Strieter R, Ransohoff R, Miller R. 1998. The chemokine growth-regulated oncogen-α promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18:10457-10463.
56. Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia Vertugo J, Berger MS, Alvarez-Buylla A. 2004. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427:740-744.
57. Scolding NJ, Rayner PJ, Sussman J, Shaw C, Compston DA. 1995. A proliferative adult human oligodendrocyte progenitor. NeuroReport 6:441-445.
58. Shankar SL, O'Guin K, Kim M, Varnum B, Lemke B, Brosnan CF, Shafit-Zagardo B. 2006. Gas6/Axl signaling activates the phosphatidilinositol 3-kinase/Akt survival pathway to protect oligodendrocytes from tumor necrosis factor-induced apoptosis. J Neurosci 26:5638-5648.
59. Stariha RL, Kim SU. 2001. Mitogen-activated protein kinase signaling in oligodendrocytes: A comparison of primary cultures and CG-4. Int J Devl Neurosci 19:427-437.
60. Stoppini L, Buchs D, Muller A. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
61. Temple S. 2001. The development of neural stem cells. Nature 414:112-117.
62. Thiele DL, Kurosaka M, Lipsky PE. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: Delineation by its sensitivity to the lysosomotrophic agent, L-leucine methyl ester. J Immunol 131:2282-2290.
63. Tsai H-H, Frost E, To V, Robinson S, french-Constant C, Geertman R, Ransohoff RM, Miller RH. 2002. The chemokine receptor controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110:373-383.
64. Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M. 2002. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol Cell Neurosci 21:602-615.
65. Volpe JJ. 2001. Perinatal brain injury: From pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 7:56-64.
66. Wang Y, Wibo L, Stricker R, Reiser G. 2006. Protease-activate receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J Neurochem 98:1046-1060.
67. Willenborg DO, Fordham SA, Cowden WB, Ramshaw IA. 1995. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol 41:31-41.
68. Wilson HC, Onischke C, Raine CS. 2003. Human oligodendrocyte precursor cells in vitro: Phenotypic analysis and differential response to growth factors. Glia 44:153-165.
69. Wolswijk G. 1998. Chronic stage multiple sclerosis contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609.
70. Xia M, Hyman BD. 2002. GROα/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for hyperphosphorylation - a role in Alzheimer's disease? J Neuroimmunol 122:55-64.
71. Zecevic N, Chen Y, Filipovic R. 2005. Contributions of the cortical subventricular zone to the development of the human cerebral cortex. J Comp Neurol 491:109-122.
72. Zhang S-C, Ge B, Duncan ID. 2000. Tracing human oligodendroglial development in vitro. J Neurosci Res 59:421-429.